Cas No.: | 1192189-69-7 |
Chemical Name: | Carbamic acid, N,N-dimethyl-, 3-[[[4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinyl]carbonyl]amino]phenyl ester |
Synonyms: | LX-7101 |
SMILES: | NCC1(CCN(C2N=CN=C3NC=C(C)C=23)CC1)C(=O)NC1C=CC=C(OC(=O)N(C)C)C=1 |
Formula: | C23H29N7O3 |
M.Wt: | 451.5215 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | LX7101 is a potent, dual LIMK and ROCK inhibitor with IC50 of 4.3/32//69/32/ nM for LIMK2/LIMK1/ROCK1/ROCK2, respectively; kinase selectivity are eveluated in a panel of binding assays including 78 different receptors and transporters at Cerep (only 5 have >60% inhibition at 10 uM); demonstrates high efficacy in mouse model of ocular hypertension, ans shows potential for the treatment of glaucoma.Other IndicationPhase 2 Clinical |